Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): A study to determine the effect of a structured SMBG intervention

Acta Diabetologica

Volumn 50, Issue 5, 2013, Pages 663-672

  Scavini, Marina ^a   Bosi, Emanuele ^a,b   Ceriello, Antonio ^c   Giorgino, Francesco ^d   Porta, Massimo ^e   Tiengo, Antonio ^f   Vespasiani, Giacomo ^g   Bottalico, Davide ^h   Marino, Raffaele ⁱ   Parkin, Christopher ^j   Bonizzoni, Erminio ^k   Cucinotta, Domenico ^l  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g Ospedale Madonna del Soccorso   (Italy)

^h ROCHE MILANO RICERCHE   (Italy)

ⁱ Medical Affairs Department Roche Diagnostics SpA   (Italy)

^j CGParkin Inc   (United States)

^k UNIVERSITY OF MILAN   (Italy)

^l UNIVERSITY OF MESSINA   (Italy)

more..

Author keywords

Diabetes medication algorithm; Patient empowerment; Randomized clinical trial; Self monitoring of blood glucose; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIET THERAPY; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; ITALY; MAJOR CLINICAL STUDY; MONITOR; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARALLEL DESIGN; PATIENT EDUCATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING OF BLOOD GLUCOSE;

ADULT; AGED; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; ITALY; MIDDLE AGED; OFFICE VISITS; PATIENT EDUCATION AS TOPIC;

EID: 84885422646     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0357-y     Document Type: Article

References (52)

1. Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
2. Nathan DM, Cleary PA, Backlund JY, et al. (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653
3. U.K. Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
4. Holman RR, Paul SK, Bethel MA, et al. (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577-1589
5. Gaede P, Vedel P, Parving HH, Pedersen O (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353:617-622
6. Gerstein HC, Miller ME, Byington RP, et al. (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559
7. Riddle MC, Ambrosius WT, Brillon DJ, et al. (2010) Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 33:983-990
8. Shiraiwa T, Kaneto H, Miyatsuka T, et al. (2005) Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients. Biochem Biophys Res Commun 336:339-345
9. Sorkin JD, Muller DC, Fleg JL, Andres R (2005) The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore longitudinal study of aging with a critical review of the literature. Diabetes Care 28:2626-2632
10. Hanefeld M, Koehler C, Schaper F, et al. ((1999) Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis 144:229-235
11. Cavalot F, Petrelli A, Traversa M, et al. (2006) Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 91:813-819
12. Temelkova-Kurktschiev TS, Koehler C, Henkel E, et al. (2000) Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 23:1830-1834
13. Esposito K, Nappo F, Marfella R, et al. (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072
14. Esposito K, Ciotola M, Carleo D, et al. (2008) Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. J Clin Endocrinol Metab 93:1345-1350
15. Hanefeld M, Cagatay M, Petrowitsch T, et al. (2004) Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. EurHeart J 25:10-16
16. Hanefeld M, Chiasson JL, Koehler C, et al. (2004) Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 35:1073-1078
17. Esposito K, Giugliano D, Nappo F, Marfella R (2004) Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 110:214-219
18. Monnier L, Mas E, Ginet C, et al. (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681-1687
19. Service FJ, Molnar GD, Rosevear JW, et al. (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19:644-655
20. International Diabetes Federation Clinical Guidelines Taskforce and International SMBG Working Group (2009) Global guideline on self-monitoring of blood glucose in non-insulin treated type 2 diabetes. International Diabetes Federation. Accessed June 2010 at http://www.idf.org
21. Parkin CG, Davidson JA (2009) Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol 3:500-508
22. Evans JM, Newton RW, Ruta DA, et al. (1999) Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ 319:83-86
23. Karter AJ, Ackerson LM, Darbinian JA, et al. (2001) Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 111:1-9
24. Nathan DM, McKitrick C, Larkin M, et al. (1996) Glycemic control in diabetes mellitus: have changes in therapy made a difference? Am J Med 100:157-163
25. Farmer A, Wade A, Goyder E, et al. (2007) Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 335:132
26. O'Kane MJ, Bunting B, Copeland M, Coates VE (2008) Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 336:1174-1177
27. Davidson MB, Castellanos M, Kain D, Duran P (2005) The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 118:422-425
28. Polonsky W, Fisher L, Schikman C, et al. (2010) The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with type 2 diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986]. BMC Fam Pract 11:37. Accessed June 2011 at http://www.biomedcentral.com/1471-2296/11/37
29. Klonoff D, Bergenstal R, Blonde LSA, et al. (2008) Consensus report of the coalition for clinical research - self-monitoring of blood glucose. J Diabetes Sci Technol 2:1030-1053
30. Kempf K, Kruse J, Martin S, ROSSO-in-praxi (2010) A self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus. Diabetes Technol Ther 12:547-553
31. Bonomo K, De Salve A, Fiora E, et al. (2010) Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin. Diabetes Res Clin Pract 87:246-251
32. Duran A, Martin P, Runkle I, et al. (2010) Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes 2:203-211
33. Polonsky WH, Fisher L, Schikman CH (2011) Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated Type 2 diabetes: results from the structured testing program study. Diabetes Care 34:262-267
34. Franciosi M, Lucisano G, Pellegrini F, Cantarello A, Consoli A, Cucco L, Ghidelli R, Sartore G, Sciangula L, Nicolucci A; for the ROSES Study Group (2011) ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med 28(7):789-796, doi: 10.1111/j.1464-5491.2011.03268.x
35. World Medical Association declaration of Helsinki (1997) Recommendations guiding physicians in biomedical research involving human subjects. JAMA 277:925-926
36. American Diabetes Association (2011) Standards of medical care in diabetes - 2011. Diabetes Care 34(Suppl 1):S11-S61
37. Nathan DM, Buse JB, Davidson MB, et al. (2006) Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 29:1963-1972
38. International Diabetes Federation Clinical Guidelines Task Force (2005) Global guideline for type 2 diabetes. Int Diabetes Federat. Accessed June 2010 at http://www.idf.org
39. Diabetologia AMD-SId. Standard Italiani per la Cura del Diabete Mellito. 2010
40. Kovatchev BP, Straume M, Cox DJ, Farhy LS (2000) Risk analysis of blood glucose data: a quantitative approach to optimizing the control of insulin dependent diabetes. J Theor Med 3:1-10
41. Kovatchev BP, Cox DJ, Gonder-Frederick LA, et al. (1998) Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 21:1870-1875
42. Kovatchev BP, Cox DJ, Gonder-Frederick L, Clarke WL (2002) Methods for quantifying self-monitoring blood glucose profiles exemplified by an examination of blood glucose patterns in patients with type 1 and type 2 diabetes. Diabetes Technol Ther 4:295-303
43. Kovatchev BP, Cox DJ, Kumar A, et al. (2003) Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Diabetes Technol Ther 5:817-828
44. Levey AS, Bosch JP, Lewis JB, for the Modification of Diet in Renal Disease Study Group (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461-470
45. Diabetes Control and Complications Trial Research Group (1988) Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT research group. Diabetes Care 11:725-732
46. Trento M, Passera P, Borgo E, et al. (2004) A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care. Diabetes Care 27:670-675
47. Peyrot M, Rubin RR (1994) Structure and correlates of diabetes-specific locus of control. Diabetes Care 17:994-1001
48. Trento M, Tomelini M, Basile M, et al. (2008) The locus of control in patients with Type 1 and Type 2 diabetes managed by individual and group care. Diabet Med 25:86-90
49. Kovatchev BP, Otto E, Cox D, et al. (2006) Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 29:2433-2438
50. Pradelles P, Grassi J, Maclouf J (1985) Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 57:1170-1173
51. Heyting A, Tolboom JT, Essers JG (1992) Statistical handling of drop-outs in longitudinal clinical trials. Stat Med 11:2043-2061
52. AMD Annals. Quality indicators of diabetes care in Italy. http://www.aemmedi.it. Accessed Nov 2011